Azithromycin-resistant Neisseria gonorrhoeae isolates in Guangzhou, China (2009-2013): Coevolution with decreased susceptibilities to ceftriaxone and genetic characteristics

BMC Infectious Diseases

Volumn 16, Issue 1, 2016, Pages

  Liang, Jing Yao ^a,b   Cao, Wen Ling ^a,b   Li, Xiao Dong ^a,b   Bi, Chao ^a,b   Yang, Ri Dong ^a,b   Liang, Yan Hua ^a,b   Li, Ping ^a,b   Ye, Xing Dong ^a,b   Chen, Xiao Xiao ^a,b   Zhang, Xi Bao ^a,b  

^a GUANGZHOU MEDICAL UNIVERSITY   (China)

^b GUANGZHOU INSTITUTE OF DERMATOLOGY   (China)

Author keywords

Antimicrobial resistance; Azithromycin; Neisseria gonorrhoeae; NG MAST

Indexed keywords

AZITHROMYCIN; CEFTRIAXONE; RNA 23S; ANTIINFECTIVE AGENT; BACTERIAL PROTEIN; MTRR PROTEIN, NEISSERIA GONORRHOEAE; REPRESSOR PROTEIN;

AGAR DILUTION; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENE; BACTERIAL GENOME; BACTERIUM ISOLATION; CHINA; COEVOLUTION; CONTROLLED STUDY; GENE FUNCTION; GENE IDENTIFICATION; GENE MUTATION; GENOME ANALYSIS; GENOTYPE; HUMAN; MALE; MINIMUM INHIBITORY CONCENTRATION; MOLECULAR DYNAMICS; MTRR GENE; MULTIANTIGEN SEQUENCE TYPING; NEISSERIA GONORRHOEAE; NONHUMAN; PENA GENE; SEQUENCE ANALYSIS; URETHRITIS; DNA SEQUENCE; DRUG EFFECTS; GENETICS; GONORRHEA; ISOLATION AND PURIFICATION; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; MUTATION; POLYMERASE CHAIN REACTION; YOUNG ADULT;

ANTI-BACTERIAL AGENTS; AZITHROMYCIN; BACTERIAL PROTEINS; CEFTRIAXONE; CHINA; DRUG RESISTANCE, BACTERIAL; GENOTYPE; GONORRHEA; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; MUTATION; NEISSERIA GONORRHOEAE; POLYMERASE CHAIN REACTION; REPRESSOR PROTEINS; RNA, RIBOSOMAL, 23S; SEQUENCE ANALYSIS, DNA; YOUNG ADULT;

EID: 84962875960     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/s12879-016-1469-3     Document Type: Article

References (30)

1. Kovari H, de Melo Oliveira MD, Hauser P, Lauchli S, Meyer J, Weber R, Zbinden R. Decreased susceptibility of Neisseria gonorrhoeae isolates from Switzerland to Cefixime and Ceftriaxone: antimicrobial susceptibility data from 1990 and 2000 to 2012. BMC Infect Dis. 2013;13:603.
2. Centers for Disease C, Prevention. Update to CDC's Sexually transmitted diseases treatment guidelines, 2010: oral cephalosporins no longer a recommended treatment for gonococcal infections. MMWR Morb Mortal Wkly Rep. 2012;61(31):590-4.
3. Bignell C, Unemo M, European STIGEB. 2012 European guideline on the diagnosis and treatment of gonorrhoea in adults. Int J STD AIDS. 2013;24(2):85-92.
4. Chen SC, Yin YP, Dai XQ, Unemo M, Chen XS. Antimicrobial resistance, genetic resistance determinants for ceftriaxone and molecular epidemiology of Neisseria gonorrhoeae isolates in Nanjing, China. J Antimicrob Chemother. 2014;69(11):2959-65.
5. Yuan LF, Yin YP, Dai XQ, Pearline RV, Xiang Z, Unemo M, Chen XS. Resistance to azithromycin of Neisseria gonorrhoeae isolates from 2 cities in China. Sex Transm Dis. 2011;38(8):764-8.
6. Yu LH, Qu Y. Analysis of antimicrobial susceptibilities of 201 Neisseria gonorrhoeae strains [in Chinese]. Zhejiang Pract Med. 2004;9:60-1.
7. Cao WL, LI XD, Bi C, Liang YH, Song WZ, Lin LY, Wu DB, Zhang L. Analysis of the drug-resistance of Neisseria gonorrhoeae to 6 types of antibiotics in certain area. Int J Lab Med. 2011;32(19):2205-6.
8. Morita-Ishihara T, Unemo M, Furubayashi K, Kawahata T, Shimuta K, Nakayama S, Ohnishi M. Treatment failure with 2 g of azithromycin (extended-release formulation) in gonorrhoea in Japan caused by the international multidrug-resistant ST1407 strain of Neisseria gonorrhoeae. J Antimicrob Chemother. 2014;69(8):2086-90.
9. Allen VG, Seah C, Martin I, Melano RG. Azithromycin resistance is coevolving with reduced susceptibility to cephalosporins in Neisseria gonorrhoeae in Ontario, Canada. Antimicrob Agents Chemother. 2014;58(5):2528-34.
10. Chisholm SA, Dave J, Ison CA. High-level azithromycin resistance occurs in Neisseria gonorrhoeae as a result of a single point mutation in the 23S rRNA genes. Antimicrob Agents Chemother. 2010;54(9):3812-6.
11. Wu A, Buono S, Katz KA, Pandori MW. Clinical Neisseria gonorrhoeae isolates in the United States with resistance to azithromycin possess mutations in all 23S rRNA alleles and the mtrR coding region. Microb Drug Resist. 2011;17(3):425-7.
12. Liao M, Gu WM, Yang Y, Dillon JA. Analysis of mutations in multiple loci of Neisseria gonorrhoeae isolates reveals effects of PIB, PBP2 and MtrR on reduced susceptibility to ceftriaxone. J Antimicrob Chemother. 2011;66(5):1016-23.
13. Katz AR, Komeya AY, Soge OO, Kiaha MI, Lee MV, Wasserman GM, Maningas EV, Whelen AC, Kirkcaldy RD, Shapiro SJ et al. Neisseria gonorrhoeae with high-level resistance to azithromycin: case report of the first isolate identified in the United States. Clin Infect Dis. 2012;54(6):841-3.
14. Cao WL, Liang JY, Li XD, Bi C, Yang RD, Liang YH, Li P, Zhong DQ, Ye XD, Zhang XB. Trends in antimicrobial resistance in Neisseria gonorrhoeae isolated from Guangzhou, China, 2000 to 2005 and 2008 to 2013. Sex Transm Dis. 2015;42(1):27-9.
15. World Health Organization. Global action plan to control the spread and impact of antimicrobial resistance in Neisseria gonorrhoeae. 2012. Available at: http://www.who.int/reproductivehealth/publications/rtis/9789241503501/en/. (19 October 2015, date last accessed).
16. Ng LK, Martin I, Liu G, Bryden L. Mutation in 23S rRNA associated with macrolide resistance in Neisseria gonorrhoeae. Antimicrob Agents Chemother. 2002;46(9):3020-5.
17. Martin IM, Ison CA, Aanensen DM, Fenton KA, Spratt BG. Rapid sequence-based identification of gonococcal transmission clusters in a large metropolitan area. J Infect Dis. 2004;189(8):1497-505.
18. Starnino S, Stefanelli P, Neisseria gonorrhoeae Italian Study G. Azithromycin-resistant Neisseria gonorrhoeae strains recently isolated in Italy. J Antimicrob Chemother. 2009;63(6):1200-4.
19. Kaiser NC, Liang LJ, Melrose RJ, Wilkins SS, Sultzer DL, Mendez MF. Differences in anxiety among patients with early- versus late-onset Alzheimer's disease. J Neuropsychiatry Clin Neurosci. 2014;26(1):73-80.
20. Centers for Disease C, Prevention. Neisseria gonorrhoeae with reduced susceptibility to azithromycin--San Diego County, California, 2009. MMWR Morb Mortal Wkly Rep. 2011;60(18):579-81.
21. Golparian D, Shafer WM, Ohnishi M, Unemo M. Importance of multidrug efflux pumps in the antimicrobial resistance property of clinical multidrug-resistant isolates of Neisseria gonorrhoeae. Antimicrob Agents Chemother. 2014;58(6):3556-9.
22. Whiley DM, Limnios EA, Ray S, Sloots TP, Tapsall JW. Diversity of penA alterations and subtypes in Neisseria gonorrhoeae strains from Sydney, Australia, that are less susceptible to ceftriaxone. Antimicrob Agents Chemother. 2007;51(9):3111-6.
23. Takahata S, Senju N, Osaki Y, Yoshida T, Ida T. Amino acid substitutions in mosaic penicillin-binding protein 2 associated with reduced susceptibility to cefixime in clinical isolates of Neisseria gonorrhoeae. Antimicrob Agents Chemother. 2006;50(11):3638-45.
24. Tomberg J, Unemo M, Davies C, Nicholas RA. Molecular and structural analysis of mosaic variants of penicillin-binding protein 2 conferring decreased susceptibility to expanded-spectrum cephalosporins in Neisseria gonorrhoeae: role of epistatic mutations. Biochemistry. 2010;49(37):8062-70.
25. Whiley DM, Goire N, Lambert SB, Ray S, Limnios EA, Nissen MD, Sloots TP, Tapsall JW. Reduced susceptibility to ceftriaxone in Neisseria gonorrhoeae is associated with mutations G542S, P551S and P551L in the gonococcal penicillin-binding protein 2. J Antimicrob Chemother. 2010;65(8):1615-8.
26. Unemo M, Shafer WM. Antimicrobial resistance in Neisseria gonorrhoeae in the 21st century: past, evolution, and future. Clin Microbiol Rev. 2014;27(3):587-613.
27. Wenling C, Xibao Z, Shi F, Minchang W, Ping L, Debiao W, Jinlan Y. Analysis of the antibiotic sensitivity of Neisseria gonorrhoeae in Guangzhou, Peoples Republic of China. Sex Transm Dis. 2000;27(8):480-2.
28. Palmer HM, Young H, Winter A, Dave J. Emergence and spread of azithromycin-resistant Neisseria gonorrhoeae in Scotland. J Antimicrob Chemother. 2008;62(3):490-4.
29. Chisholm SA, Neal TJ, Alawattegama AB, Birley HD, Howe RA, Ison CA. Emergence of high-level azithromycin resistance in Neisseria gonorrhoeae in England and Wales. J Antimicrob Chemother. 2009;64(2):353-8.
30. Galarza PG, Alcala B, Salcedo C, Canigia LF, Buscemi L, Pagano I, Oviedo C, Vazquez JA. Emergence of high level azithromycin-resistant Neisseria gonorrhoeae strain isolated in Argentina. Sex Transm Dis. 2009;36(12):787-8.